
Home > Newsroom > 2010 > Takeda Included in the FTSE4Good Global Index for the Sixth Consecutive Year
Main contents starts here
July 9, 2010
Osaka, Japan, July 9, 2010 - Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it has been included for the sixth consecutive year in “the FTSE4Good Global Index of the FTSE4Good Index Series”, which is one of the world’s premier indices for Socially Responsible Investment (SRI)[*1].
Provided by the FTSE Group[*2], the FTSE4Good Global Index is a benchmark SRI index and is one of the most important indices for investors, who take into consideration corporate social responsibility (CSR) initiatives of each company, when making investment decision. The FTSE Group applies its own set of social and environmental criteria[*3] to select from some 2,400 companies from 24 countries. As of May 31, 2010, 663 companies were included, 184 of which are Japanese.
Takeda has once again been selected for this Index for having met FTSE’s criteria in the areas of “Environmental Management”, “Climate Change Mitigation and Adaptation”, “Countering Bribery”, and “Up holding Human and Labour Rights.”
As a pharmaceutical company that is related to the people’s lives, Takeda will remain committed to the fulfillment of its social responsibility as a global entity, with a view towards realizing its Mission of “striving towards better health for patients worldwide through leading innovation in medicine.”
# # #
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
# # #